Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate in Septic Shock
NCT07716956Recruiting
- Sponsor
- Alexandria University
- Start
- Jul 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Randomised trial of magnesium sulfate in septic shock (2 arms), sponsored by Alexandria University. Primary endpoints: Total cumulative dose of norepinephrine up to 60 days and Duration of norepinephrine therapy up to 60 days. Started Jul 2026; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT07716956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07716956.